Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
New Research: GLP-1 Medications and Broader Health Benefits A large-scale study using U.S
E-commerce-style checkout
Triple receptor activity: GLP-1, GIP, and glucagon Appetite and satiety pathway support Energy expenditure and fat metabolism research Body weight reduction in clinical trials Potential metabolic health improvements A possible future option for clients who have plateaued on existing therapies In a phase 2 trial published in The New England Journal of Medicine, adults with obesity who received Retatrutide for 48 weeks had substantial reductions in body weight, with the 12 mg group showing a mean percentage change of -24.2% compared with -2.1% for placebo
It also plays a role in taste and smell perception, which matters when appetite is already suppressed and food needs to be as appealing as possible
US$ 21.70
US$ 25.41
US$ 27.05
US$ 20.16
US$ 28.22
US$ 23.30
US$ 26.15
